Note: Hospira (HSP) is being added to the US 1 list as of January 17. Pfizer (PFE) is being removed from the US 1 list as part of a rebalancing but continues to be rated a BUY.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.